Mitsubishi UFJ Asset Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Buy |
7,461
+1,326
| +22% | +$37.7K | ﹤0.01% | 973 |
|
|
2025
Q1 | $181K | Buy |
6,135
+514
| +9% | +$15.2K | ﹤0.01% | 965 |
|
|
2024
Q4 | $171K | Sell |
5,621
-3,292
| -37% | -$100K | ﹤0.01% | 1010 |
|
|
2024
Q3 | $409K | Sell |
8,913
-844
| -9% | -$38.8K | ﹤0.01% | 878 |
|
|
2024
Q2 | $399K | Sell |
9,757
-29,606
| -75% | -$1.21M | ﹤0.01% | 879 |
|
|
2024
Q1 | $1M | Sell |
39,363
-1,803
| -4% | -$46K | ﹤0.01% | 804 |
|
|
2023
Q4 | $394K | Buy |
41,166
+15,654
| +61% | +$150K | ﹤0.01% | 946 |
|
|
2023
Q3 | $163K | Buy |
25,512
+1,403
| +6% | +$8.95K | ﹤0.01% | 1042 |
|
|
2023
Q2 | $267K | Buy |
24,109
+1,108
| +5% | +$12.3K | ﹤0.01% | 1001 |
|
|
2023
Q1 | $353K | Buy |
23,001
+1,063
| +5% | +$16.3K | ﹤0.01% | 966 |
|
|
2022
Q4 | $444K | Buy |
21,938
+2,035
| +10% | +$41.2K | ﹤0.01% | 920 |
|
|
2022
Q3 | $325K | Buy |
19,903
+348
| +2% | +$5.68K | ﹤0.01% | 967 |
|
|
2022
Q2 | $284K | Buy |
+19,555
| New | +$284K | ﹤0.01% | 1002 |
|